Genxone Spolka Akcyjna
GX1 | WAR
Overview
Corporate Details
- ISIN(s):
- PLGENXN00013
- LEI:
- 25940043REFNZY18T558
- Country:
- Poland
- Address:
- SUCHY LAS ZŁOTNIKI, KOBALTOWA 6, 62-002 SUCHY LAS
- Website:
- http://www.genxone.eu
- Sector:
- Health Care
- Industry:
- Health Care Technology
Description
Genxone Spółka Akcyjna is at the forefront of biotechnology, specializing in Next Generation Sequencing (NGS) and medical diagnostics. As one of Poland's pioneers and a leading global player in nanopore sequencing technology, we offer innovative solutions across various sectors, including healthcare and research. Our services encompass extensive genomic analyses, including whole genome sequencing and tailored bioinformatics, providing vital insights for disease diagnosis and management. Our commitment to quality is underscored by our ISO 9001:2015 certification. With a growing portfolio, including cutting-edge diagnostics for infectious diseases and microbiome analysis through our NANOBIOME project, Genxone is well-positioned for sustained growth. We invite investors to join us in redefining healthcare through innovative science.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-03-08 14:25 |
Regulatory News Service
Podpisanie umowy warunkowej o istotnym znaczeniu - Content (PL)
|
Polish | 1.2 KB | |
| 2024-03-06 16:41 |
Takeover Announcement Report
Informacja o wyborze najkorzystniejszej oferty - Content (PL)
|
Polish | 1.8 KB | |
| 2023-11-16 15:32 |
Regulatory News Service
Podpisanie umowy warunkowej o istotnym znaczeniu - Content (PL)
|
Polish | 1.1 KB | |
| 2023-11-14 14:32 |
Takeover Announcement Report
Informacja o wyborze najkorzystniejszej oferty - Content (PL)
|
Polish | 1.7 KB | |
| 2023-10-23 16:34 |
Regulatory News Service
Aktualizacja informacji na temat umowy warunkowej o istotnym znaczeniu - Conten…
|
Polish | 948 bytes | |
| 2023-07-20 15:09 |
Regulatory News Service
Zawarcie istotnej umowy - Content (PL)
|
Polish | 1.0 KB | |
| 2023-06-19 15:31 |
Declaration of Voting Results & Voting Rights Announcements
Lista akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
|
Polish | 470 bytes | |
| 2023-05-22 15:37 |
Annual Report
Sprawozdanie RN genXone za 2022 rok
|
Polish | 991.6 KB | |
| 2023-05-22 15:37 |
Declaration of Voting Results & Voting Rights Announcements
Projekty uchwał WZA genXone SA
|
Polish | 284.6 KB | |
| 2023-05-22 15:37 |
General Meeting Notice
Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Spółki genXone SA
|
Polish | 291.5 KB | |
| 2023-05-22 15:37 |
General Meeting Notice
Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Spółki genXone S.A. na d…
|
Polish | 6.6 KB | |
| 2023-05-09 15:57 |
Regulatory News Service
Podpisanie umowy warunkowej o istotnym znaczeniu - Content (PL)
|
Polish | 857 bytes | |
| 2023-05-05 16:54 |
Related Party Transactions
Informacja o wyborze najkorzystniejszej oferty - Content (PL)
|
Polish | 1.5 KB | |
| 2023-04-26 17:03 |
Regulatory News Service
Aktualizacja informacji na temat prac badawczych w ramach projektu NANOBIOME - …
|
Polish | 1.7 KB | |
| 2023-03-21 08:05 |
Directors' Dealings
Zawiadomienia_o_transakcjach_osoby_zobowiazanej_Jakub_Swadzba_20230320.pdf
|
Polish | 9.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Deversify Health AB | Sweden | DEV | |
|
Diagonal Bio AB | Sweden | DIABIO | |
| EDX Medical Group Plc | United Kingdom | N/A | ||
|
Elekta | Sweden | EKTA | |
|
Elos Medtech | Sweden | ELOS | |
|
Episurf | Sweden | EPIS | |
|
FluoGuide A/S | Denmark | FLUO | |
|
GELION PLC | United Kingdom | GELN | |
|
Genetic Analysis AS | Norway | GEAN | |
|
Genomed Spolka Akcyjna | Poland | GEN |